(Total Views: 412)
Posted On: 03/03/2021 9:39:04 PM
Post# of 653
$RLFTF DD by Larry on Ya-h00: This answers a question for me. I have continually wondered why there has been no trials started in Europe.
These quotes come directly from a RT valuation report: “Syneos Health: a global clinical research organization (CRO), is expected to run the European phase IIb/III clinical trial of RLF-100 in COVID-19 induced ARDS (if such a study is deemed necessary for approval by European regulators) as well as future trials in other indications to be conducted in Europe.”
“Start EU phase IIb/III trial of RLF-100 IV in COVID-19 induced ARDS in Q1 2021 (may not be required if US “COVID-AIV” trial shows statistically significant survival data).
https://s33569fc90c7564f1.jimcontent.com/down...5JAN21.pdf
These quotes come directly from a RT valuation report: “Syneos Health: a global clinical research organization (CRO), is expected to run the European phase IIb/III clinical trial of RLF-100 in COVID-19 induced ARDS (if such a study is deemed necessary for approval by European regulators) as well as future trials in other indications to be conducted in Europe.”
“Start EU phase IIb/III trial of RLF-100 IV in COVID-19 induced ARDS in Q1 2021 (may not be required if US “COVID-AIV” trial shows statistically significant survival data).
https://s33569fc90c7564f1.jimcontent.com/down...5JAN21.pdf
(0)
(0)
$MJ
